Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02136797
What this trial is testing

Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
CMV InfectionPersistent CMV Viremia
Memorial Sloan Kettering Cancer Center 77
Testing effectiveness (Phase 2)UnknownNCT03339700
What this trial is testing

Addition of Gemcitabine to Pre Allo-HSCT Conditioning for Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia, Adult
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 15
Not applicableStudy completedNCT03719092
What this trial is testing

High Dose Vitamin A in Preventing Gastrointestinal GVHD in Participants Undergoing Donor Stem Cell Transplant

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation Recipient
Ohio State University Comprehensive Cancer Center 62
Testing effectiveness (Phase 2)Ended earlyNCT03615105
What this trial is testing

Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors

Who this might be right for
Acute Lymphoid Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Myeloid Leukemia (CML)+3 more
Memorial Sloan Kettering Cancer Center 9
Testing effectiveness (Phase 2)Ended earlyNCT04526288
What this trial is testing

CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome With Excess Blasts-2Myeloid Neoplasm
Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT04888741
What this trial is testing

Methods of T Cell Depletion Trial (MoTD)

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelomonocytic Leukemia+6 more
University of Birmingham 400
Testing effectiveness (Phase 2)Ended earlyNCT01530256
What this trial is testing

Exploratory Safety Study of ALD518 in Subjects With Steroid-refractory Acute Graft Versus Host Disease (GVHD)

Who this might be right for
Acute GvHD
CSL Behring 3
Testing effectiveness (Phase 2)Study completedNCT00047060
What this trial is testing

Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome

Who this might be right for
Mycosis FungoidesSezary Syndrome
National Heart, Lung, and Blood Institute (NHLBI) 5
Not applicableUnknownNCT05590091
What this trial is testing

Study on Intelligent Nutrition Support Therapy for Hematopoietic Stem Cell Transplantation Recipients

Who this might be right for
Nutrition Aspect of CancerStem Cell Transplant Complications
Hebei Yanda Ludaopei Hospital 106
Large-scale testing (Phase 3)UnknownNCT01423500
What this trial is testing

ALL-SCT BFM International- HSCT in Children and Adolescents With ALL

Who this might be right for
Lymphoblastic Leukemia, Acute, Childhood;
St. Anna Kinderkrebsforschung 405
Not applicableStudy completedNCT03448471
What this trial is testing

Severe Fatigue in Stem Cell Transplantation

Who this might be right for
Stem Cell TransplantationFatigue
Gazi University 49
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06986382
What this trial is testing

Phase 1b/2a Trial of Allogeneic HSCT From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset Medically Refractory Crohn Disease

Who this might be right for
Crohn Disease
Stanford University 14
Large-scale testing (Phase 3)Ended earlyNCT03870750
What this trial is testing

Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmNon-Neoplastic Hematologic and Lymphocytic Disorder
Fred Hutchinson Cancer Center 458
Testing effectiveness (Phase 2)Looking for participantsNCT06783790
What this trial is testing

Avapritinib Combined With Azacitidine and Venetoclax in the Treatment of Relapsed AML After Allo-HSCT

Who this might be right for
AML (Acute Myelogenous Leukemia)
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableUnknownNCT06241274
What this trial is testing

Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT

Who this might be right for
MoxibustionHematopoietic Stem Cell TransplantationHemorrhagic Cystitis+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Not applicableStudy completedNCT04506320
What this trial is testing

Novel Drugs After Allo-HSCT in Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaStem Cell Transplant
Gruppo Italiano Trapianto di Midollo Osseo 202
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06075238
What this trial is testing

Blinatumomab Prevents Recurrence of R/R ALL After Allo-HSCT

Who this might be right for
Leukemia, Lymphoid
Sichuan University 68
Early research (Phase 1)Study completedNCT05673876
What this trial is testing

Assess the Safety and Pharmacokinetics of GDC-8264 in Combination With Standard of Care in Participants With Acute Graft-Versus-Host Disease (aGVHD)

Who this might be right for
Acute Graft-versus-host Disease
Genentech, Inc. 7
Large-scale testing (Phase 3)Not Yet RecruitingNCT07774377
What this trial is testing

Chidamide Maintenance to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation in Acute T-Lymphoblastic Leukemia/Lymphoma

Who this might be right for
T-Cell Acute Lymphoblastic LeukemiaT-Cell Lymphoblastic Lymphoma
First Affiliated Hospital of Zhejiang University 132
Testing effectiveness (Phase 2)Study completedNCT00002502
What this trial is testing

Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Memorial Sloan Kettering Cancer Center
Next Page